Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice.

Yuichi Fumimoto, Akifumi Matsuyama, Hiroshi Komoda, Hanayuki Okura, Chun Man Lee, Anna Nagao, Toshirou Nishida, Toshinori Ito, Yoshiki Sawa

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Subcutaneous tissue was proposed as an optimal transplant site for islets in treatment for type I diabetes mellitus. However, vascular networks in subcutaneous tissue are too poor in their natural state to allow survive and function of the transplanted graft. This study examined whether subcutaneous implantation of adipose tissue-derived stromal cells (ADSCs) combined with minced adipose tissue could form vascular-rich beds suitable to support islet transplantation. ADSCs were isolated from male C57BL/6J mouse inguinal subcutaneous adipose tissue. ADSCs and minced adipose tissue were implanted syngeneically in subcutaneous tissue of the back of recipient mice. Four weeks later, vascularization in the implanted subcutaneous tissue was evaluated, and islets were transplanted onto the vascularized pockets. Mice that received ADSCs mixed with minced adipose tissue showed a richly vascularized pocket of tissue with significantly higher capillary density than in mice implanted with either ADSCs or minced adipose tissue only. All recipient mice of the combination ADSCs and minced adipose tissue group showed correction in blood glucose level within a week after islet transplantation and maintained normoglycemia for over 8 weeks. These mice became hyperglycemic again after removal of the subcutaneous grafts. This novel method will expand the indications for islet transplant therapy and potential clinical application of cell-based therapy.

Original languageEnglish
Pages (from-to)437-444
Number of pages8
JournalTissue engineering. Part C, Methods
Volume15
Issue number3
DOIs
Publication statusPublished - 01-09-2009
Externally publishedYes

Fingerprint

Subcutaneous Fat
Stromal Cells
Blood Vessels
Adipose Tissue
Tissue
Subcutaneous Tissue
Transplants
Islets of Langerhans Transplantation
Obese Mice
Groin
Grafts
Cell- and Tissue-Based Therapy
Type 1 Diabetes Mellitus
Inbred C57BL Mouse
Blood Glucose
Medical problems

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{79f82df560de4a39a1285fd9e22dfabc,
title = "Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice.",
abstract = "Subcutaneous tissue was proposed as an optimal transplant site for islets in treatment for type I diabetes mellitus. However, vascular networks in subcutaneous tissue are too poor in their natural state to allow survive and function of the transplanted graft. This study examined whether subcutaneous implantation of adipose tissue-derived stromal cells (ADSCs) combined with minced adipose tissue could form vascular-rich beds suitable to support islet transplantation. ADSCs were isolated from male C57BL/6J mouse inguinal subcutaneous adipose tissue. ADSCs and minced adipose tissue were implanted syngeneically in subcutaneous tissue of the back of recipient mice. Four weeks later, vascularization in the implanted subcutaneous tissue was evaluated, and islets were transplanted onto the vascularized pockets. Mice that received ADSCs mixed with minced adipose tissue showed a richly vascularized pocket of tissue with significantly higher capillary density than in mice implanted with either ADSCs or minced adipose tissue only. All recipient mice of the combination ADSCs and minced adipose tissue group showed correction in blood glucose level within a week after islet transplantation and maintained normoglycemia for over 8 weeks. These mice became hyperglycemic again after removal of the subcutaneous grafts. This novel method will expand the indications for islet transplant therapy and potential clinical application of cell-based therapy.",
author = "Yuichi Fumimoto and Akifumi Matsuyama and Hiroshi Komoda and Hanayuki Okura and Lee, {Chun Man} and Anna Nagao and Toshirou Nishida and Toshinori Ito and Yoshiki Sawa",
year = "2009",
month = "9",
day = "1",
doi = "10.1089/ten.tec.2008.0555",
language = "English",
volume = "15",
pages = "437--444",
journal = "Tissue Engineering - Part C: Methods",
issn = "1937-3384",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. / Fumimoto, Yuichi; Matsuyama, Akifumi; Komoda, Hiroshi; Okura, Hanayuki; Lee, Chun Man; Nagao, Anna; Nishida, Toshirou; Ito, Toshinori; Sawa, Yoshiki.

In: Tissue engineering. Part C, Methods, Vol. 15, No. 3, 01.09.2009, p. 437-444.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice.

AU - Fumimoto, Yuichi

AU - Matsuyama, Akifumi

AU - Komoda, Hiroshi

AU - Okura, Hanayuki

AU - Lee, Chun Man

AU - Nagao, Anna

AU - Nishida, Toshirou

AU - Ito, Toshinori

AU - Sawa, Yoshiki

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Subcutaneous tissue was proposed as an optimal transplant site for islets in treatment for type I diabetes mellitus. However, vascular networks in subcutaneous tissue are too poor in their natural state to allow survive and function of the transplanted graft. This study examined whether subcutaneous implantation of adipose tissue-derived stromal cells (ADSCs) combined with minced adipose tissue could form vascular-rich beds suitable to support islet transplantation. ADSCs were isolated from male C57BL/6J mouse inguinal subcutaneous adipose tissue. ADSCs and minced adipose tissue were implanted syngeneically in subcutaneous tissue of the back of recipient mice. Four weeks later, vascularization in the implanted subcutaneous tissue was evaluated, and islets were transplanted onto the vascularized pockets. Mice that received ADSCs mixed with minced adipose tissue showed a richly vascularized pocket of tissue with significantly higher capillary density than in mice implanted with either ADSCs or minced adipose tissue only. All recipient mice of the combination ADSCs and minced adipose tissue group showed correction in blood glucose level within a week after islet transplantation and maintained normoglycemia for over 8 weeks. These mice became hyperglycemic again after removal of the subcutaneous grafts. This novel method will expand the indications for islet transplant therapy and potential clinical application of cell-based therapy.

AB - Subcutaneous tissue was proposed as an optimal transplant site for islets in treatment for type I diabetes mellitus. However, vascular networks in subcutaneous tissue are too poor in their natural state to allow survive and function of the transplanted graft. This study examined whether subcutaneous implantation of adipose tissue-derived stromal cells (ADSCs) combined with minced adipose tissue could form vascular-rich beds suitable to support islet transplantation. ADSCs were isolated from male C57BL/6J mouse inguinal subcutaneous adipose tissue. ADSCs and minced adipose tissue were implanted syngeneically in subcutaneous tissue of the back of recipient mice. Four weeks later, vascularization in the implanted subcutaneous tissue was evaluated, and islets were transplanted onto the vascularized pockets. Mice that received ADSCs mixed with minced adipose tissue showed a richly vascularized pocket of tissue with significantly higher capillary density than in mice implanted with either ADSCs or minced adipose tissue only. All recipient mice of the combination ADSCs and minced adipose tissue group showed correction in blood glucose level within a week after islet transplantation and maintained normoglycemia for over 8 weeks. These mice became hyperglycemic again after removal of the subcutaneous grafts. This novel method will expand the indications for islet transplant therapy and potential clinical application of cell-based therapy.

UR - http://www.scopus.com/inward/record.url?scp=70449715447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449715447&partnerID=8YFLogxK

U2 - 10.1089/ten.tec.2008.0555

DO - 10.1089/ten.tec.2008.0555

M3 - Article

VL - 15

SP - 437

EP - 444

JO - Tissue Engineering - Part C: Methods

JF - Tissue Engineering - Part C: Methods

SN - 1937-3384

IS - 3

ER -